Important Information for Investors of Geron Corporation:
New York, April 15, 2025 – The Rosen Law Firm, a global investor rights law firm, alerts investors of Geron Corporation (NASDAQ: GERN) regarding a securities class action lawsuit and a significant deadline.:
Class Action Lawsuit:
Geron Corporation investors who purchased securities between February 28, 2024, and February 25, 2025, both dates inclusive (the “Class Period”), are encouraged to contact the firm before the May 12, 2025 lead plaintiff deadline. The lawsuit alleges that Geron Corporation issued materially misleading statements and failed to disclose material information to the investing public.
Compensation without Out-of-Pocket Costs:
If you purchased Geron securities during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a contingency class action lawsuit and seeks to appoint the lead plaintiff who will represent the interests of all class members in the action.
Effect on Individual Investors:
For individual investors, this means that if the allegations in the lawsuit are proven in court, they may be eligible for compensation for their losses. The Rosen Law Firm’s contingency fee arrangement means that investors would not pay any out-of-pocket costs to participate in the lawsuit.
Effect on the World:
The potential implications of this case extend beyond the investors directly involved. If the allegations in the lawsuit are proven, it could lead to increased scrutiny of Geron Corporation’s business practices and potentially impact investor confidence in the biotech industry as a whole. It also highlights the importance of accurate and transparent reporting for publicly traded companies.
Conclusion:
If you purchased Geron Corporation securities between February 28, 2024, and February 25, 2025, and believe that Geron Corporation misrepresented material information to investors, you may be entitled to compensation. Contact The Rosen Law Firm before the May 12, 2025 lead plaintiff deadline to learn more about your potential rights and how to participate in the action. The Rosen Law Firm’s expertise in securities litigation ensures that you receive the best possible representation.
- Geron Corporation investors who purchased securities between February 28, 2024, and February 25, 2025, are encouraged to contact The Rosen Law Firm before May 12, 2025.
- The lawsuit alleges that Geron Corporation issued materially misleading statements and failed to disclose material information to the investing public.
- Investors may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.
- The potential implications of this case extend beyond the investors directly involved and could impact investor confidence in the biotech industry as a whole.
